Abstract
Objectives
Because of the large number of cases of visceral leishmaniasis (VL) recorded in Brazil over the last few years, this disease has been showing characteristics different from previously known ones. We report cases of pregnant women treated for VL, describing their course and outcome and the chemotherapeutic medication used according to the clinical signs and symptoms of each patient.
Study design
We report five cases of pregnant women treated for VL in a central-western region of Brazil.
Results
No case of vertical transmission was observed, even in patients who were treated after delivery. One of the patients with a late diagnosis made after the onset of symptoms died. Thus, the treatment of VL during pregnancy reduces maternal mortality and the rate of vertical transmission of the disease, being safe and effective as long as the disease is diagnosed early.
Conclusion
At present, amphotericin B and its derivatives appear to be the best therapeutic option for the mother–child binomial.
Similar content being viewed by others
References
Pagliano P, Carannante N, Rossi M, Gramiccia M, Gradoni L, Faella FS, Gaeta GB (2005) Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature. J Antimicrob Chemother 55:229–233
Mellor AL, Munn DH (2000) Immunology at the maternal–fetal interface: lessons for T cell tolerance and suppression. Annu Rev Immunol 18:367–391
Kumar A, Mittal M, Prasad S (2001) Treatment of leishmaniasis in pregnancy. Int J Gynaecol Obstet 72:189–190
Bouyou-Akotet MK, Issifou S, Meye JF, Kombila M, Ngou-Milama E, Luty AJ, Kremsner PG, Mavoungou E (2004) Depressed natural killer cell cytotoxicity against Plasmodium falciparum-infected erythrocytes during first pregnancies. Clin Infect Dis 38:342–347
Pearson RD, Sousa AQ (1996) Clinical spectrum of leishmaniasis. Clin Infect Dis 22:1–13
Eltoum IA, Zijlstra EE, Ali MS, Ghalib HW, Satti MM, Eltoum B, el-Hassan AM (1992) Congenital kala-azar and leishmaniasis in the placenta. Am J Trop Med Hyg 46:57–62
Figueiró-Filho EA, Duarte G, El Beitune P, Quintana SM, Maia TL (2004) Visceral leishmaniasis (kala-azar) in pregnancy. Infect Dis Obstet Gynecol 12:31–40
Yadav TP, Gupta H, Satteya U, Kumar R, Mittal V (1989) Congenital kala-azar. Ann Trop Med Parasitol 835:535–537
Brustoloni YM, Lima RB, da Cunha RV, Dorval ME, Oshiro ET, de Oliveira AL, Pirmez C (2007) Sensitivity and specificity of polymerase chain reaction in Giemsa-stained slides for diagnosis of visceral leishmaniasis in children. Mem Inst Oswaldo Cruz 102:497–500
Paumgartten FJR, Chahoud I (2001) Embryotoxicity of meglumine antimoniate in the rat. Reprod Toxicol 15:327–331
Silveira BP, Araujo Sobrinho J, Leite LF, Sales MN, Gouveia Mdo S, Mathias RL, Guedes Filho RA, Barbosa SM (2003) Premature birth after use of pentavalent antimonial: case report. Rev Soc Bras Med Trop 36:523–525
Thakur CP, Singh RK, Hassan SM, Kumar R, Narain S, Kumar A (1999) Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases. Trans R Soc Trop Med Hyg 93:319–323
Mueller M, Balasegaram M, Koummuki Y, Ritmeijer K, Santana MR, Davidson R (2006) A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan. J Antimicrob Chemother 58:811–815
Thakur CP, Sinha GP, Sharma V, Barat D (1993) The treatment of kala-azar during pregnancy. Natl Med J India 6:263–265
Murray HW (2001) Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrob Agents Chemother 45:2185–2197
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Figueiró-Filho, E.A., El Beitune, P., Queiroz, G.T. et al. Visceral leishmaniasis and pregnancy: analysis of cases reported in a central-western region of Brazil. Arch Gynecol Obstet 278, 13–16 (2008). https://doi.org/10.1007/s00404-007-0532-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-007-0532-0